Polymorphism of apolipoproteine E in relation with Alzheimer and vascular dementia

Cellular and Molecular Neurobiology

Volumn 26, Issue 7-8, 2006, Pages 1219-1224

  Gdovinová, Zuzana ^a   Habalová, Viera ^a   Novosadová, Zuzana ^a  

^a P J AFÁRIK UNIVERSITY   (Slovakia)

Author keywords

Alzheimer disease; Apolipoprotein E; Vascular dementia

Indexed keywords

APOLIPOPROTEIN E; RESTRICTION ENDONUCLEASE;

ADULT; AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; CHI SQUARE TEST; CONFIDENCE INTERVAL; CONTROLLED STUDY; CRUDE GARTS ODDS RATIO; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIAGNOSTIC PROCEDURE; DISEASE ASSOCIATION; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE PHENOTYPE CORRELATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MINIMENTAL STATE EXAMINATION; MULTIINFARCT DEMENTIA; NINCDS ADRDA CRITERION; NINDS AIREN CRITERION; ONSET AGE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; STATISTICAL ANALYSIS;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; APOLIPOPROTEIN E4; DEMENTIA, VASCULAR; FEMALE; GENE FREQUENCY; HETEROZYGOTE DETECTION; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC;

EID: 33845549164     PISSN: 02724340     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10571-006-9043-y     Document Type: Article

References (15)

1. Bales, K. R., Verina, T., and Dodel, R. C. (1997). Lack of apolipoprotein E dramatically reduces amyloid beta-peptide deposition. Nat. Genet. 17:263-264.
2. Brecht, W. J., Hartus, F. M., Chány, S., Tesseur, I., Yu, G. Q., Xu, Q., Dee Fish, J., Wyss-Coray, T., Buttini, M., Mucke, L., Mahely, R. W., and Juany, Y. (2004). Neurospecific apolipoprotein (4 proteolysis is associated with increased tau phosphorylation in brains of transgenic mice. J. Neurosci. 24:2527-2534.
3. Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. V., Roses, A. D., Haines, J. L., and Pericak-Vance, M. A. (1993). Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimers' disease in late onset families. Science 261:921-923.
4. Chapman, J., Estupinam, J., Asherov, A., and Goldfarb, L. G. (1996). A simple and efficient method for apolipoprotein E genotype determination. Neurology 46:1484-1485.
5. Davignon, J., Gregg, R. E., and Sing, C. F. (1988). Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis 8:1-21.
6. Ewbank, D. C. (2002). Mortality differences by APOE genotype estimated from demographic synthesis. Genet. Epidemiol. 22:146-155.
7. Fratiglioni, M. D., Launer, L. J., Andersen, K., Breteler, M. M. B., Copeland, J. R. M., Dartigues, J. - F., Lobo, A., Martinez-Lage, J., Soininen, H., and Hofman, A. (2000). Incidenece of dementia and major subtypes in Europe: A collaborative study of population-based cohorts. Neurology 54(Suppl):S10-S15.
8. Handelmann, G. E., Boyles, J. K., Weisgraber, K. H., Mahley, R. W., and Pitas, R. E. (1992). Effects of apolipoprotein E, beta-very low density lipoproteins, and cholesterol on the extension of neurites by rabbit dorsal root ganglion neurons in vitro. J. Lipid Res. 33:1677-1688.
9. Lehtimäki, T., Pirttilä, T., Mehta, P. D., Wisniewski, H. M., Frey, H., and Nikkari, T. (1995). Apolipoprotein E (ApoE) polymorphism and its influence on ApoE concentration in the cerobrospinal fluid in Finnish patients with Alzheimers' disease. Hum. Genet. 95:39-42.
10. Mechirova, E., and Domorakova, I. (2004). NADPH-diaphorase activity in the spinal cord after ischemic injury and the effects of pretreatment with Ginkgo biloba extract (EGb 761). Acta Histochemica 104:427-430.
11. Prince, M., Lovestone, S., Cervilla, J., Joels, S., Powell, J., Russ, C., and Mann, A. (2000). The association between ApoE and deemtnia does not seem to be mediated by vascular factors. Neurology 54:397-402.
12. Saunders, A. M., Hulette, C., and Welsh-Bohmer, K. A. (1996). Specificity, sensitivity, and predictive value apolipoprotein-E genotyping for sporadic Alzheimers' disease. Lancet 348:90-93.
13. Sparks, D. L. (1997). Coronary artery disease, hypertension, ApoE, and cholesterol: A link to Alzheimers' disease?. Ann. N.Y. Acad. Sci. (1997). 826:128-146.
14. Strittmatter, W. J., Saunders, A. M., Schmechel, D., Pericak-Vance, M., Enghild, J., Salvesen, G. S., and Roses, A. D. (1993). Apolipoprotein E: High-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimers' disease. Proc. Natl. Acad. Sci. U.S.A. 90:1977-1981.
15. Strittmatter, W. J., Weisgraber, K. H., Goedert, M., Saunders, A. M., Huang, D., Corder, E. H., Dong, L. M., Jakes, R., Alberts, M. J., Gilbert, J. R., Han, S. H, Hulette, C., Einstein, G., Schmechel, D. E., Pericak-Vance, M. A., and Roses, A. D. (1994). Hypothesis: Microtubule instability and paired helical filament formation in the Alzheimer disease brain are related to apolipoprotein genotype. Exp. Neurol. 125:163-171.